Key result
AKAP12 influences cardiovascular disease by compartmentalizing PKA signaling and regulating β-adrenergic receptors.
Key points are not available for this paper at this time.
Design
Review
AKAP12 may modulate cardiac β-adrenergic signaling; leaves open its viability as a therapeutic target pending targeted studies.
-adrenergic-receptor) stimulation, the AKAP12 signalosome is recruited near the plasma membrane and binds tightly to β-AR. Thus, one major function of AKAP12 is compartmentalizing PKA (protein kinase A) signaling near the plasma membrane. In addition, it is involved in regulating desensitization, downregulation, and recycling of β-AR. In this review, the critical roles of AKAP12 as a scaffold protein in mediating signaling downstream GPCRs (G protein-coupled receptor) are discussed with an emphasis on its reported and potential roles in cardiovascular disease initiation and progression.
No takes yet. Share an insight, caveat, or question.
Qasim et al. (2020) studied this question. AKAP12 acts as a critical scaffold protein that compartmentalizes PKA signaling and regulates β-adrenergic receptors, influencing cardiovascular disease initiation and progression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: